The TESLA trial revealed that endovascular thrombectomy did not lead to improved outcomes after 90 days in patients with large core stroke compared to standard care.
Dr. Ansari noted the results are counterintuitive as earlier trials indicated significant benefits from thrombectomy by targeting patients with small core infarcts.
The TESLA trial aimed to investigate whether patients with larger infarcts could still benefit from thrombectomy, addressing potential patient selection biases in prior studies.
Ultimately, the findings of the TESLA trial underscore the need for cautious evaluation when considering thrombectomy for patients with large core strokes.
Collection
[
|
...
]